Acquired hemophilia A: a review of recent data and new therapeutic options (Q36356147)

13 August 2017

title

Acquired hemophilia A: a review of recent data and new therapeutic options (English)

1 reference

13 August 2017

0 references

0 references

1 reference

1

Massimo Franchini

1 reference

Giancarlo Maria Liumbruno

13 August 2017

7

object named as

Giancarlo Maria Liumbruno

1 reference

13 August 2017

4

Carlo Mengoli

1 reference

13 August 2017

Stefania Vaglio

2

1 reference

13 August 2017

Giuseppe Marano

3

1 reference

13 August 2017

Sara Gentili

5

1 reference

13 August 2017

Simonetta Pupella

6

1 reference

13 August 2017

publication date

25 April 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

1-7

1 reference

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired haemophilia: an overview for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired haemophilia A: a 2013 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

The past and future of haemophilia: diagnosis, treatments, and its complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired hemophilia in pediatrics: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Postpartum acquired factor VIII inhibitors: results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Postpartum acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired haemophilia and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired haemophilia in association with organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired factor VIII inhibitors in oncohematology: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Laboratory, clinical and therapeutic aspects of acquired hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Summary report of the First International Conference on inhibitors in haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Immunological aspects of inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Genetic markers in acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

The use of recombinant activated factor VII in patients with acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Treatment of acquired haemophilia with factor eight inhibitor bypassing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Recombinant activated factor VII: mechanisms of action and current indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

DDAVP in acquired hemophilia A: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Extracorporeal immunoadsorption for the treatment of coagulation inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Inhibitor eradication with rituximab in haemophilia: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Rituximab in the treatment of adult acquired hemophilia A: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Rituximab for the treatment of acquired antibodies to factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10245332.2017.1319115

10.1080/10245332.2017.1319115

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference